Safety and Efficacy of Triple Combination Therapy With Dorzolamide Hydrochloride / Brimonidine Tartrate / Timolol Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension

Exclusion Criteria

• •Use of dorzolamide or carbonic anhydrase within 4 weeks
• •Any other active ocular disease other than ocular hypertension or glaucoma (eg, uveitis, ocular infections or severe dry eye)
• •Required chronic use of ocular medications other than study medication during the study (intermittent use of certain products eg, artificial tears are permitted)
• •Use of oral, injectable or topical ophthalmic steroids within 21 days
• •Any eye laser surgery within 3 months
• •Any intraocular surgery (eg cataract surgery) within 6 months